AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Endometrial Ablation Devices Market Analysis 2016-2019 & Forecast 2026 - ResearchAndMarkets.com

March 28, 2019

DUBLIN--(BUSINESS WIRE)--Mar 28, 2019--The “Global Endometrial Ablation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026” report has been added to ResearchAndMarkets.com’s offering.

The global Endometrial Ablation market was valued at USD 985.8 Mn in 2017 and is expected to reach USD 1,588.3 Mn by 2026, expanding at a CAGR of 5.3% from 2018 to 2026.

Market Insights

There are some novel technologies that are expected to assist the market growth in the near future such as Minerva (Argon-bipolar technology), Cryotherapy, Aegea (Low-Pressure Vapor), and Lina Librata (Glycerine-filled Balloon). The key advantages possessed by endometrial ablation are a lower rate of serious side-effects, and post-surgery hospitalization. Endometrial ablation device market faces challenges such as low treatment access, lack of trained physicians, and noticeable failure rates.

Radiofrequency endometrial ablation devices accounted for the largest share of around 55% due to key market driving factors such as high safety & fast recovery, increasing awareness related to this technique in developing countries, and high preference from several medical practitioners. On November 19, 2014, Hologic had launched NovaSure for the treatment of abnormal uterine bleeding and it’s was effectively accepted in the market by many surgeons, cost-efficiency & quick patient recovery has been key advantages assisting overall growth of NovaSure.

North America was identified as the largest endometrial ablation market in the year 2017 attributing to the overwork & sedentary lifestyle in women that assists prevalence of abnormal uterine bleeding and increasing awareness related to uterine bleeding & complexities associated with post-endometrial ablation surgeries. The Asia Pacific will maintain its dominance throughout the forecast period from 2018 to 2026 due to key driving factors such as increasing accessibility & availability of novel endometrial ablation devices and rising public awareness related to abnormal uterine bleeding and other complexities.

Market Competition Assessment

The growth of endometrial ablation is at a significant pace and key companies operating in this market are focusing on the development of safe & efficient endometrial ablation devices.

The major market players in this market are Boston Scientific Corporation, Olympus Corporation, Hologic Corporation, Smith & Nephew plc, Minerva Surgical, Inc., KARL STORZ GmbH & Co. KG, The Cooper Companies, Inc., Medtronic plc, Richard Wolf GmbH, Ethicon, Inc., AngioDynamics Inc. among others.

Key Market Movements

  • Increasing demand for minimally invasive endometrial ablation is expected to assist the future market growth
  • Mounting prevalence of gynecological disorders is also assisting the awareness related to an availability of treatments
  • Technologically endometrial ablation devices are developing, focusing specifically on the efficiency and swift recovery
  • A few recalls related with endometrial ablation devices has been one of the key restraints restricting the market growth ”

Topics Covered

Chapter 1. Preface

1.1. Report Scope and Description

1.1.1. Study Purpose

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Methodology

1.2.1. Phase I-Secondary Research

1.2.2. Phase II-Primary Research

1.2.3. Phase III-Expert Panel Review

1.2.4. Assumptions

1.2.5. Approach Adopted

Chapter 2. Executive Summary

2.1. Global Endometrial Ablation Devices Market Portraiture

2.2. Global Endometrial Ablation Devices Market, by Type of Device, 2017 (US$ Mn)

2.3. Global Endometrial Ablation Devices Market, by End-User, 2017 (US$ Mn

2.4. Global Endometrial Ablation Devices Market, by Geography, 2017 vs 2026 (Value %)

Chapter 3. Global Endometrial Ablation Devices Market: Market Dynamics and Future Outlook

3.1. Market Overview

3.2. Drivers

3.2.1. Increasing prevalence of menorrhagia and other menstrual disorders

3.2.2. Technological development coupled with supportive reimbursement policies

3.3. Challenges

3.3.1. Stringent regulatory policies have increased the rate of product recall

3.4. Opportunities

3.4.1. Increasing market penetration in developing economies expected to meet the unmet needs in the near future

3.5. Attractive Investment Proposition, by Geography, 2017

3.6. Competitive Landscape

3.6.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Endometrial Ablation Devices Market, by Type of Device, 2016 - 2026 (US$ Mn)

4.1. Overview

4.2. Hysteroscopy Devices

4.3. Radiofrequency Endometrial Ablation Devices

4.4. Thermal Balloon Ablation Devices

4.5. Hydrothermal Ablation Devices

4.6. Microwave Endometrial Ablation Devices

4.7. Cryoablation Devices

4.8. Electrical Ablation Devices

Chapter 5. Global Endometrial Ablation Devices Market, by End-Users, 2016 - 2026 (US$ Mn)

5.1. Overview

5.2. Hospitals

5.3. Ambulatory Surgical Centers

5.4. Clinics

Chapter 6. Global Endometrial Ablation Devices Market, by Geography, 2016 - 2026 (US$ Mn)

6.1. Overview

6.2. North America Endometrial Ablation Devices Market Analysis, 2016 - 2026

6.3. Europe Endometrial Ablation Devices Market Analysis, 2016 - 2026

6.4. Asia Pacific Endometrial Ablation Devices Market Analysis, 2016 - 2026

6.5. Latin America Endometrial Ablation Devices Market Analysis, 2016 - 2026

6.6. Middle East & Africa (MEA) Endometrial Ablation Devices Market Analysis, 2016 - 2026

Chapter 7. Company Profiles

7.1. Hologic Corporation

7.1.1. Business Description

7.1.2. Financial Information (Subject to data availability)

7.1.3. Product Portfolio

7.1.4. Key Developments

7.2. Boston Scientific Corporation

7.3. Olympus Corporation

7.4. Minerva Surgical Inc.

7.5. Smith & Nephew PLC

7.6. The Cooper Companies

7.7. KARL STORZ GmbH & Co. KG

7.8. Richard Wolf GmbH

7.9. Ethicon Inc.

7.10. Medtronic PLC

7.11. AngioDynamics Inc.

For more information about this report visit https://www.researchandmarkets.com/research/4j6mpc/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190328005514/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Medical Devices,Surgical Procedures ,Surgical Devices

KEYWORD:

INDUSTRY KEYWORD: SURGERY HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/28/2019 08:57 AM/DISC: 03/28/2019 08:57 AM

http://www.businesswire.com/news/home/20190328005514/en